Clusterheadaches.com Message Board (http://www.clusterheadaches.com/cgi-bin/yabb/YaBB.cgi)
Cluster Headache Help and Support >> Cluster Headache Specific >> Clusterbusters makes the news!
(Message started by: moonhoney2 on Aug 17th, 2006, 3:26pm)

Title: Clusterbusters makes the news!
Post by moonhoney2 on Aug 17th, 2006, 3:26pm
Read an article in the Chicago Suntimes about Clusterbusters.    Love  the last paragraph. Like sufferers are really going to wait years and years to see if maybe the gov't will approve this treatment.  http://www.clicksmilies.com/s0105/sprachlos/speechless-smiley-034.gif

http://www.suntimes.com/output/news/cst-nws-shrooms16.html

BTW, Sean has been PF since about a week or two after his dose.  http://www.thefamilyplayground.com/phpbb2/images/smiles/icon_banana.gif

Title: Re: Clusterbusters makes the news!
Post by Sandy_C on Aug 17th, 2006, 4:01pm
All I can say is WOW!  Fatastic article!  All we can hope for at this time is some recognition that shrooms, LSD, LSA are viable options for clusterheadaches, and that these alternatives will begin to be prescibed for us.

Thanks for posting this info.  It give me hope.

Sandy

Title: Re: Clusterbusters makes the news!
Post by chopmyheadoff on Aug 18th, 2006, 2:16am
Any exposure is good imho !!

the more GP's that know all the details of CH , the less people that go un/miss diagnosed !!!

chop

Title: Re: Clusterbusters makes the news!
Post by SophiaK on Aug 18th, 2006, 12:41pm
I can't help but think the drug companies will latch on to this kind of study and find a way to get approval to sell it and it will cost a freakin fortune for those of us that need it.
I can see shrooms being a 'controlled ' substance and that's what will bring it to the market place. But then what do I know.

Title: More news!
Post by cluster on Aug 18th, 2006, 3:26pm
http://images.journals.elsevierhealth.com/images/journalimages/1474-4422/00050009_cov200h.gif


http://www.thelancet.com/journals/laneur

The Lancet Neurology, Current Issue, Volume 5, Number 9, September 2006:

Hallucinogen Research inspires “neurotheology”
The perceived benefits of psychedelic drugs are not commonly thought to extend to health. However, new research suggests that subhallucinogenic doses of the active compound in magic mushrooms and LSD may help prevent cluster headache. In a feature, Kelly Morris investigates potential neurological uses of psychedelic drugs.....

The full text online is $ 30,-  - can anybody lend me a fiver?  ;)

Painfree wishes,
Friedrich



Title: Re: More news!
Post by Pinkfloyd on Aug 18th, 2006, 3:53pm

on 08/18/06 at 15:26:13, cluster wrote:
http://www.thelancet.com/journals/laneur

The Lancet Neurology, Current Issue, Volume 5, Number 9, September 2006:

Hallucinogen Research inspires “neurotheology”


Hi Friedrich,

Thanks for the heads-up. I'll work on getting a copy.

Bobw



Title: Re: Clusterbusters makes the news!
Post by Bond007 on Aug 18th, 2006, 7:17pm
Hey Bob,

I don't mind shelling out the $30 for the premium content on the Lancent website -- unless you've already done it.  Just let me know.  I also have no problem reposting the entire article over here and giving the reference where I got it from.  What the hell, share and share alike, right?   ;)

Title: Re: Clusterbusters makes the news!
Post by Pinkfloyd on Aug 19th, 2006, 1:33am

on 08/18/06 at 19:17:08, Bond007 wrote:
I don't mind shelling out the $30 for the premium content on the Lancent website -- unless you've already done it.


I appreciate it. Give me 24 hours to see if I can get one for free ;-)
Then you can send in 10.00 for the premium content, to each of, Clusterbusters, OUCH and ch.com  ;;D

Thanks for the offer, really. It's very thoughtful. I'll let you know.

Bobw

Title: Re: Clusterbusters makes the news!
Post by Pinkfloyd on Aug 19th, 2006, 12:11pm
The Lancet...

Taken from:
The Lancet Neurology
Volume 5, Issue 9 , September 2006, Page 732

Hallucinogen research inspires “neurotheology”

Kelly Morris

For decades, the benefits of psychedelic drugs have mostly been  
explored through individual experimentation. Whether these  
hallucinogens can induce true mystical experiences has been debated.  
In a landmark paper, US researchers now report that psilocybin, the  
active compound in “magic mushrooms”, induced mystical experiences  
identical to other reported mystical states in more than 60% of  
participants (Psychopharmacology 2006; published online July 7. DOI:
10.1007/s00213-006-0457-5). Moreover, after 2 months, 79% of  
participants reported enhanced well-being. So what has prompted these  
investigations and how might such substances improve health?

“In the 1950s and 1960s, basic science and applied research studies  
were taking place with hallucinogens, offering hints that they might  
be of value in psychotherapy, addiction treatment, and creativity  
enhancement, and suggestions that the hallucinogens can occasion  
mystical-type experiences. Laws enacted in response to excesses of  
the ‘psychedelic 1960s' stopped almost all that work, leaving some  
promising threads dangling”, notes lead author Roland Griffiths  
(Johns Hopkins University School of Medicine, Baltimore, USA).

John Halpern (Harvard Medical School and McLean Hospital, Belmont,  
USA), who is instigating studies on psilocybin and LSD for cluster  
headaches with study lead Andrew Sewell, says the “temperature of the  
day” is insufficient to wholly preclude research. “Many years of hard  
groundwork have set the stage for the carefully crafted studies now  
being reported on. Such research could always have been performed but  
it is up to investigators to initiate such work and to justify that  
the potential benefits may outweigh risks.”

The mechanisms and potential benefits of hallucinogens are being  
studied worldwide. Whether these benefits are due to  
psychopharmacological action, induced psychological changes, or both  
is unclear.

Halpern and colleagues did a questionnaire study of 53 people taking  
psilocybin or LSD for cluster headaches. Although Halpern says that  
speculation on mechanisms is premature before efficacy studies are  
done, 22 of the 53 patients reported partial or complete efficacy  
from subhallucinogenic doses. If proven in rigorous studies, such  
efficacy might lie in the serotonergic action that characterises most  
hallucinogens.

<<SNIP>>

Ultimately, study of hallucinogens may reveal that psychopharmacology  
underpins these potentially transformative experiences. Solomon  
Snyder of Johns Hopkins comments on the Psychopharmacology paper:  
“[By] showing that one can responsibly conduct clinical research with  
psychedelic drugs and by confirming the mystical influences of these  
agents, Griffiths et al may help resurrect psychedelic drugs as major  
tools in probing the molecular bases of consciousness”. Further, he  
notes that serotonin, discovered via LSD studies, may underpin the  
integration of sensory perception, so changes in serotonin systems  
could be related to the ego-transcendence that occurs in mystical  
experiences.
-------

I've snipped out a bit here and there....if anyone wants a full text copy, email or IM me. Although everything that applies to clusters is in the above text.

Bobw


Title: Re: Clusterbusters makes the news!
Post by Bond007 on Aug 19th, 2006, 1:48pm
Bob, you are amazing!  I'm not gonna ask, but that's fantastic!  The donations will be forthcoming.



Clusterheadaches.com Message Board » Powered by YaBB 1 Gold - SP 1.3.1!
YaBB © 2000-2003. All Rights Reserved.